Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fonds Stratégique des Transitions is a long-term French private equity / crossover fund created in 2023 and managed by ISALT, dedicated to financing the industrial scale-up of innovative French SMEs and mid-caps in four strategic sectors (alternative energies, decarbonised industry, quality of life including health, and technological innovation); it has raised close to €300M (target >€300M) with cornerstone investors such as Caisse des Dépôts, Fonds Stratégique de Participations, and EIF, and has already invested in companies including Tissium (medtech), Intact (agri-foodtech), Energies de Loire (solar), Unseenlabs (space), Epsor (fintech), Via Sana (healthcare real-estate/services), and Sources (water/waste)
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fonds Stratégique des Transitions.